Prospective Thinking in Hormone-Responsive Breast Cancer
Hormone Receptor Positive Malignant Neoplasm of Breast
About this trial
This is an interventional basic science trial for Hormone Receptor Positive Malignant Neoplasm of Breast
Eligibility Criteria
Inclusion Criteria:
- Age 18-80 years
- Female
- Must have a history of hormone responsive breast cancer treated with curative intent and have been recommended/prescribed adjuvant HT (tamoxifen, anastrozole, letrozole or exemestane) by their physician.
Exclusion Criteria:
- Recurrent breast cancer
- Adjuvant hormone therapy is no longer medically appropriate/advisable
- Incapable/ without capacity to provide personal consent
- Suffers from cognitive or physical impairments which interfere with medication self- administration and/or participation in episodic thinking
- Receiving HT for metastatic disease
Sites / Locations
- Virginia Tech Carilion Research Institute
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Episodic future thinking
Episodic recent thinking (control)
Participants will complete a guided interview designed to elicit a number of personalized events that are likely to occur during various future time frames (e.g., 1 day, 1 week, 3 months, 1 year, etc.), as well as text cues designed to prompt episodic future thinking (e.g., "In 3 months, I will be at my daughter's wedding"). Text cues will be presented during subsequent behavioral tasks and participants will be asked to think vividly about these events.
Participants will complete a guided interview designed to elicit a number of personalized events that occurred in the recent past (e.g., earlier today, yesterday), as well as text cues designed to prompt episodic thinking (e.g., "Earlier today, I was playing tennis with my wife."). Text cues will be presented during subsequent behavioral tasks and participants will be asked to think vividly about these events.